Elsevier

Brain Research

Volume 520, Issues 1–2, 18 June 1990, Pages 6-13
Brain Research

Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density

https://doi.org/10.1016/0006-8993(90)91686-BGet rights and content

Abstract

Recently, we reported bilateral increases in striatal neurotensin (NT) levels following unilateral 6-hydroxydopamine lesion of the nigrostriatal dopaminergic pathway. In the present study, the effect of unilateral striatal lesions with quinolinic acid (QA, 300 nmol) or ibotenic acid (IBO, 130 nmol) on striatal NT levels and binding site densities were analyzed in order to investigate other possible regulations of NT systems. QA and IBO injection decreased γ-aminobutyric acid (GABA) levels and [125I]iodosulpride (a specific D2 receptor antagonist) binding site densities in the lesioned striatum, indicating degeneration of striatal intrinsic neurons. Striatal dopaminergic terminals were not altered by QA as shown by the lack of changes in [3H]dihydrotetrabenazine ([3H]TBZOH, a specific ligand of the vesicular monoamine transporter) binding site densities. Moreover, QA lesion induced an increase in NT levels and a decrease in NT binding sites in the lesioned striatum without any change in the contralateral structure. In contrast to QA, IBO might destroy a certain proportion of dopaminergic terminals in the lesioned striatum, as shown by a 54% decrease in [3H]TBZOH binding. Furthermore, IBO lesion enhanced striatal NT levels bilaterally, while NT binding sites decreased in the lesioned striatum and increased in the contralateral side. The present results suggest that not only dopaminergic neurons but also striatal intrinsic neurons may control NT systems in the striatum.

References (54)

  • HaubrichD.R. et al.

    Neurotensin effects on brain dopaminergic systems

    Brain Research

    (1982)
  • IsacsonO. et al.

    Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue

    Neuroscience

    (1985)
  • KiltsC.D. et al.

    Differential effects of antipsychotic drugs on the neurotensin concentration of discrete rat brain nuclei

    Biochem. Pharmacol.

    (1988)
  • KitabgiP. et al.

    Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution

    Eur. J. Pharmacol.

    (1987)
  • MasuoY. et al.

    Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density

    Brain Research

    (1990)
  • MazzariS. et al.

    Intracerebral quinolinic acid injection in the rat: effects on dopaminergic neurons

    Brain Research

    (1986)
  • McGeerP.L. et al.

    Neostriatal choline acetylase and cholinesterase following selective brain lesions

    Brain Research

    (1971)
  • MerchantK.M. et al.

    Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens

    Eur. J. Pharmacol.

    (1989)
  • MoyseE. et al.

    Distribution of neurotensin binding sites in rat brain: a light microscopic radioautographic study using monoiodo[125I]Tyr3-neurotensin

    Neuroscience

    (1987)
  • MyersR.D. et al.

    In vivo release of dopamine during perfusion of neurotensin in substantia nigra of the unrestrained rat

    Peptides

    (1983)
  • PinnockR.D.

    Neurotensin depolarizes substantia nigra dopamine neurons

    Brain Research

    (1985)
  • PrechtW. et al.

    Blockage of caudate-evoked inhibition of neurons in the substantia nigra by picrotoxin

    Brain Research

    (1971)
  • QuirionR. et al.

    Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals

    Brain Research

    (1985)
  • SadoulJ.L. et al.

    Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors

    Biochem. Biophys. Res. Commun.

    (1984)
  • StoofJ.C. et al.

    Stimulation of D-2 receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin

    Eur. J. Pharmacol.

    (1982)
  • YoungW.S. et al.

    Neurotensin receptor localization by light microscopic autoradiography in rat brain

    Brain Research

    (1981)
  • ZahmD.S. et al.

    Asymmetrical distribution of neurotensin immunoreactivity following unilateral injection of 6-hydroxydopamine in rat ventral tegmental area (VTA)

    Brain Research

    (1989)
  • Cited by (31)

    • Neurotensin receptors as modulators of glutamatergic transmission

      2008, Brain Research Reviews
      Citation Excerpt :

      The possible location of NTS1 on axon terminals suggests that NT may modulate dopaminergic neuronal transmission by acting presynaptically on receptors located on either dopaminergic or non-dopaminergic afferent terminals. The presence of NTS1 on presynaptic DA terminals in the caudate was confirmed by the findings obtained using 6-hydroxydopamine (6-OHDA) lesioned rats (Herve et al., 1986; Dilts and Kalivas, 1989; Schotte and Leysen, 1989; Masuo et al., 1990; Cadet et al., 1991). Moreover, experiments performed by lesioning intrinsic striatal neurons or cortico-striatal projections, suggest that NTS1 are not exclusively located on DA terminals (Goedert et al., 1984; Masuo et al., 1990).

    • Hippocalcin protects hippocampal neurons against excitotoxin damage by enhancing calcium extrusion

      2007, Neuroscience
      Citation Excerpt :

      In the present study, we injected QUIN directly into the hippocampus and restrained the dose in order to cause only partial damage in the CA1 subfield. QUIN has excitotoxic effects that are milder than those of kainic acid and ibotenic acid, NMDA and metabotropic glutamate receptor agonist, and lesions caused by QUIN spare the axons of the neurons (Schwarcz and Shoulson, 1987; Masuo et al., 1990). In our preliminary experiments, Nissl-stained pyknotic cells had already appeared in the CA1 pyramidal cell layer in +/+ mice 12 h after QUIN injection.

    View all citing articles on Scopus
    View full text